Studies on the Metabolic Fate of Cabergoline (III) : Identification of Liver Metabolites, Distribution of Brain, and Effect on Hepatic Drug-Metabolizing Enzymes in Rats

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-08-30

著者

• Ujiie A

  Central Research Laboratories Kissei Pharmaceutical Co. Ltd.

• Nakamura Shunji

  キッセイ薬品工業株式会社薬物動態研究所

• Nishiyama Masahiko

  キッセイ薬品工業株式会社薬物動態研究所

• Nishiyama Masahiko

  キッセイ薬品工業株式会杜中央研究所

• GOTOH Yasumasa

  キッセイ薬品工業株式会社薬物動態研究所

• MIYAGI Masaharu

  キッセイ薬品工業株式会社薬物動態研究所

• UJIIE Arao

  キッセイ薬品工業株式会社薬物動態研究所

関連論文

• A Rapid- and Short-Acting Hypoglycemic Agent KAD-1229 Improves Post-Prandial Hyperglycemia and Diabetic Complications in Streptozotocin-Induced Non-Insulin-Dependent Diabetes Mellitus Rats
• Dopamine Receptor Affinities in Vitro and Stereotypic Activities in Vivo of Cabergoline in Rats
• Studies on the Metabolic Fate of Cabergoline (III) : Identification of Liver Metabolites, Distribution of Brain, and Effect on Hepatic Drug-Metabolizing Enzymes in Rats
• Studies on the Metabolic Fate of Cabergoline (II) : Absorption, Distribution and Excretion after Repeated Oral Administration to Rats, and Transfer into the Fetus and Milk of Rats
• Studies on the Metabolic Fate of Cabergoline (I) : Absorption, Distribution, and Excretion after a Single Oral Administration to Rats
• Tranilast Suppresses Intimal Hyperplasia in the Balloon Injury Model and Cuff Treatment Model in Rabbits
• Disposition of ^3H-KAA-276 after Intratracheal Administration to Male Rats

スポンサーリンク